Roquette Wins NIE New Ingredient Award for Low Nitrite METHOCEL™ HPMC
Award | 2025 NIE New Ingredient Award – Pharmaceutical Safety & Quality |
|---|---|
Presented by | Nutrition Industry Executive (NIE) Magazine |
Date | September 2025 |
Pharma Innovation
Roquette’s Health & Pharma Solutions Business Group is proud to announce that Low Nitrite METHOCEL™ has received the 2025 NIE New Ingredient Award, recognizing its innovative contribution to pharmaceutical safety and quality.
Presented by Nutrition Industry Executive (NIE), the New Ingredient Awards spotlight breakthrough ingredients that advance health, safety, and performance across the life sciences. Roquette’s Low Nitrite METHOCEL™ stood out for its role in addressing one of the industry’s most pressing challenges: nitrosamine contamination.
Excipient Innovation for Patient Safety
Nitrosamines — classified as potential carcinogens, have become a major concern for regulators and manufacturers. Roquette’s Low Nitrite METHOCEL™ is a modified cellulose excipient designed to support nitrosamine mitigation strategies in oral solid dosage forms.
This award underscores Roquette’s commitment to excipient innovation, regulatory alignment, and patient safety, and reflects our broader mission to deliver sustainable, high-performance solutions to the pharmaceutical industry.
“We’re honored to receive this recognition from NIE. It validates our ongoing efforts to support customers with excipients that meet evolving safety standards while maintaining formulation performance.”
— Michael Baumann,
Global Product Manager,
Roquette’s Health & Pharma Solutions Business Group
